2023 Flow Diversion in Fibromuscular Dysplasia: A Decade of Experience

View at publisher Summarise with VIRAT
Authors: Eric A. Grin, Daniel D. Wiggan, Eleanor Gutstadt, Vera Sharashidze, Charlotte Y. Chung, Jacob F. Baranoski, Caleb W. Rutledge, Howard Antony Riina, Peter Kim Nelson, Maksim Shapiro, Eytan Raz, Erez Zeev Nossek
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Flow diversion for aneurysm treatment in patients with fibromuscular dysplasia (FMD) may be challenging due to the irregular vasculature. Endovascular treatment in FMD has been reported only once before and did not delve specifically into flow diversion. METHODS: Natural language processing queried our institution’s medical records for intracranial embolization cases from 2014-2024, screening for “fibromuscular dysplasia.” Confirmed cases of Pipeline embolization in cerebrovascular FMD were retrospectively reviewed. RESULTS: Thirty-one patients with cerebrovascular FMD underwent 39 PED treatments. Most patients were female (90%), White (42%), and had multiple aneurysms (55%). Median age was 59.0 years (22.8-75.7 years). FMD involved the carotid arteries in 55% of patients, vertebral arteries in 10%, and both in 35%. Incidental vessel dissections were found in 23% of patients. In 31 (79.5%) cases, the guidewire and catheter used for treatment were navigated through a carotid or vertebral artery affected by FMD to treat a distal aneurysm. in 13 (33.3%) cases, PEDs were deployed within or overlapping an affected irregular vessel segment. Most treatments targeted saccular aneurysms (82%) in the anterior circulation (96%). Multiple PEDs were used in 62% of treatments. No intraoperative complications occurred. Complete aneurysm occlusion was achieved at six months in 84% of cases and at most recent follow-up in 97%. At a median clinical follow-up of 3.6 years (0.7-9.9 years), two patients (6%) suffered adverse events. One patient with metastatic cancer had a central retinal artery occlusion six years postoperatively after discontinuing dual antiplatelet therapy against medical advice. Another patient, lost to follow-up for five years, died from a ruptured de novo aneurysm. CONCLUSIONS: With proper antiplatelet regimens, flow diversion with PEDs can effectively and safely treat patients with FMD.

Fields of Study & Subjects

Intracranial Aneurysms: Treatment and Complications Cerebrovascular and Carotid Artery Diseases Vascular Malformations Diagnosis and Treatment

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
245–245
Publication date
26 March 2026
Language
EN